Physician profile
Robert Augustine Ottaviani
NPI 1518934686
$1,077.81
in general payments reported to CMS, 2019-2025
8 companies · $282 in 2025
The $282 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.37 · 2021: $12.69 · 2022: $236 · 2023: $376 · 2024: $136 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $759 · Travel and Lodging: $20.25 · Education: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $759.36 |
| Travel and Lodging | $20.25 |
| Education | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $633.56 | 2019-2025 | Oxford, Tapestry, Identity |
| Stryker Corporation | $239.93 | 2021-2023 | Mako |
| Biomerieux INC | $61.27 | 2023 | |
| Medtronic, INC. | $58.21 | 2022-2024 | Plasmablade(Tm) |
| Heron Therapeutics, INC. | $37.24 | 2025 | Zynrelef |
| Depuy Synthes Sales INC. | $17.67 | 2025 | Na |
| Smith+Nephew, INC. | $15.00 | 2024 | |
| Conmed Corporation | $14.93 | 2025 | Visiclear |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Ottaviani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.